Zygotic division into a blastocyst establishes the extra-embryonic tissues (trophoblast layer or outer cell mass) and hypoblast (extraembryonic endoderm) that support the embryonic epiblast (inner cell mass) early in embryogenesis. Trophoblasts secrete an array of hormones [1] [2] [3] 6 including hCG during the migration of the blastocyst through the fallopian tube and its implantation into the endometrium. The dramatic elevation in the production of hCG by trophoblasts at this early embryonic stage (from 5 to ≥1000 mIU/mL in the maternal serum) 6,7 signals both the corpus lutea and trophoblast 2 to synthesize and secrete P 4 8,9 which is required for the maintenance of the endometrium, blastocyst attachment and synctiotrophoblast proliferation into the endometrium 10 .
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Given the close spatial localization of the developing trophoblast layer to the epiblast, it is conceivable that trophoblast-associated hormones directly signal the growth and development of the epiblast. Evidence supporting this concept includes our recent observations that, 1) hCG markedly increases hESC expression of the adhesion and neuritogenic protein amyloid-β precursor protein 11 , and
2) P 4 signaling is necessary for human blastulation 3 . To examine the functionality of trophoblastic signaling to the epiblast, we examined if the LHCGR was expressed by pluripotent hESC. Full-length mature LHCGR (92-kDa) 6 was detected in hESC and expression was not altered upon differentiation into embryoid bodies (EBs), which resemble early post-implantation embryos (blastocyst) 12 , or into neuroectodermal rosettes, which consist of >90% columnar neural precursor cells (NPC) and are the in vitro equivalent of a rudimentary neural tube 13 (Fig. 1a) . Decreased Oct-3/4 expression together with brightfield analysis indicated lineage commitment and loss of pluripotency during the differentiation of hESC colonies into rosettes. RT-PCR of RNA extracted from pluripotent hESC confirmed the presence of LHCGR message (data not shown). The comparable level of LHCGR expression between the different cell lineages is suggestive of a basal requirement for LH/hCG signaling during these early stages of embryogenesis.
hCG is mitogenic towards epithelial and endothelial cells of the endometrium and is a marker of carcinogenesis 14 . Treatment of hESC with a physiologically relevant concentration of hCG (500 mIU/mL) in growth factor-free TESR1 culture media resulted in a 3.3-fold increase in cell proliferation after 6 d (Fig. 1b) , a response that did not vary with hCG concentration (5-50,000 mIU/mL; data not shown). Surprisingly, a similar increase (3.7-fold) in hESC proliferation was observed in growth factorfree TESR1 culture media, suggesting the autocrine production of hCG/LH or other mitogenic factors by hESC. RT-PCR amplification of RNA extracted from pluripotent hESC using sequence specific primers confirmed the presence of both hCGβ isoform V and LHβ message (Fig. 1c) . While full length mature 30-kDa LH protein (α-GSU + LHβ subunits) and other variants of LH (47-kDa and 60-kDa) 15 could be detected by immunoblot analysis (Fig. 1d) , hCG was not detectable (data not shown) as previously reported 2 , suggesting differential translational control of the expression of these gonadotropins.
To examine the requirement for hCG/LH signaling in the proliferation of hESC in vitro, we treated hESC with P-antisense oligonucleotides against LHCGR. P-antisense oligonucleotides significantly decreased hESC proliferation (48%) compared to sense oligonucleotide treated hESC (Fig. 2a) . To confirm that hESC production of LH or trophoblastic production of hCG promotes hESC proliferation, we treated hESC with increasing concentrations of an antibody against amino acids 15-38 of the extracellular activation site of LHCGR (Fig. 2b ) 16 . This antibody significantly reduced hESC proliferation in a dose-dependent fashion compared to 6 d untreated controls (Fig. 2c) . Addition of hCG to hESC treated with this blocking antibody reversed this effect, confirming the specificity of the antibody for the receptor and of hCG signaling for hESC proliferation. The high binding affinities (Kd ≈ 0.4-5.5 x 10 -10 M) of hCG/LH for the human receptor 17, 18 indicates that the autocrine production of even low concentrations of these gonadotropins by hESC (or trophoblasts) is sufficient to signal hESC proliferation. A low level of hCG/LH expression by hESC/trophoblasts also is consistent with the low binding capacity (~2.2 fmol/mg tissue) of hCG for LHCGR 17 . In this respect, knockdown of Oct4 expression in hESC induces hCG and Gcm1 expression 19 and indicates any small differentiation of hESC in our cultures may provide sufficient hCG for hESC proliferation. Together, these results suggest the presence of a hCG/LH-dependent mechanism that signals embryonic growth.
hCG functions to increase trophoblast and corpus luteal P 4 production 8, 9 . To examine if hCG induces steroidogenesis in hESC as in steroidogenic tissues, we examined the expression of steroid acute regulatory protein (StAR), a key rate-limiting step in the production of sex steroids in reproductive tissues. hESC were found to express StAR mRNA and protein (37-kDa, 30-kDa and 20-kDa variants; Fig. 3a ). Since truncation of the 37-kDa to the 30/32-kDa variants of StAR is indicative of increased cholesterol transport across the mitochondrial membrane for steroidogenesis 20 , we treated hESC with hCG and measured P 4 secretion into the media. hCG (500 mIU/mL) treatment increased P 4 secretion into the media 15-fold (Fig. 3b) . To understand the regulation of sex steroid synthesis by hESC, we treated hESC with increasing concentrations of gonadotropins (Fig. 3c) . LHCGR expression was suppressed by treatment with increasing hCG and LH concentrations (Fig. 3c) . Similarly, to determine whether gonadotropins regulate StAR expression and processing in hESC, as they do in the gonads 21 , Fig. 3a) with differentiation of hESC into EBs and rosettes is consistent with a decreased requirement for steroidogenesis in these more differentiated cell lineages. Together, these results indicate negative feedback pathways exist for the regulation of hCG/LH signaling and cholesterol uptake for the synthesis of sex steroids in hESC and differentiating lineages.
Increasing concentrations of hCG suppress the pluripotent marker Oct-3/4 ( Fig. 3c ), suggesting hCG, or steroid production initiated by hCG signaling, can direct lineage commitment. To test the effects of sex steroids on hESC proliferation and differentiation, we treated hESC with E 2 , P 4 , and E 2 + P 4 and observed a significant decrease in cell proliferation by 29%, 16% and 23%, respectively, compared to untreated control (Fig. 4a) . These results were consistent with the slight decrease in cell proliferation observed following hCG treatment (Fig. 1b ) that induced significant P 4 secretion (Fig. 3d) .
A screen of germline markers indicated that P 4 , and to a lesser extent E 2 , increase the expression of nestin, an early marker of NPC formation, in hESC (Fig. 4b) . Interestingly, E 2 'priming' has been shown to be required for induction of P 4 receptor (PR) expression in other tissues 22 . Thus, the increase in nestin expression with E 2 treatment may reflect increased PR expression together with endogenous P 4 signaling, and explain the current requirement for serum priming of hESC colonies in the preparation of neuroectodermal rosettes. Previous studies have demonstrated the importance of P 4 and related steroids as neurotrophic agents that promote adult neurogenesis, neuronal survival and neuroprotection 4, 5, 23 .
The induction of nestin expression by P 4 reveals a pivotal function for this pregnancy hormone during ectoderm formation. To confirm the requirement for P 4 signaling in epiblast development, hESC colonies just prior to entering the EB stage were treated with or without the PR antagonist RU-486 24 .
When compared to controls, colonies treated with RU-486 failed to form cystic structures (cavitation) and instead formed solid irregular spheres (Fig. 4c ) that did not express nestin (data not shown). We next examined the requirement for P 4 signaling during neurulation. hESC colonies grown into a pre-EB stage were treated with either P 4 , RU-486, P 4 + RU-486, or neither. In the presence of P 4 , control rosettes displayed a minimum of three rosette structures inside of the cavity (Fig. 4c) . Compared to controls, pre-EB's treated without P 4 or with RU-486 retained a spherical shape but failed to form rosettes with columnar neuroectodermal cells after 17 days in culture (Fig. 4c) . Morphological changes were more severe in the absence of P 4 than with RU-486. That neuroectoderm failed to form was confirmed by the absence of nestin expression in RU-486 treated compared to P 4 treated pre-EBs (Fig.   4d ). These results indicate the obligatory role of P 4 signaling in gastrulation and neurulation during early embryogenesis.
hCG/LH signaling via the LHCGR increases hESC proliferation, but also P 4 25 . Since hESC express gonadotropins (Fig. 1c) , and hCG signaling promotes P 4 production (Fig. 3d ) which induces lineage commitment towards a neuroectodermal phenotype (Figs. 4b, c) , we tested whether hCG might act to differentiate hESC toward a neuronal lineage. hCG treatment induced nestin expression (205-kDa variant) in hESC (Fig. 4e) , indicating endogenous gonadotropin production by hESC (Fig. 1 ) or trophoblastic cells 2 may be sufficient for NPC formation, thereby explaining the extrinsic hormonal signals regulating the 'default pathway' of hESC differentiation into neuronal lineages 25 .
These results suggest that trophoblastic hCG production adjacent to the embryoblast is required not only for trophoblast steroidogenesis and attachment to the uterine wall, but also for signaling normal growth and development of the epiblast. While the structural importance of P 4 and alloprogesterone has previously been recognized by its early synthesis (by at least day 13) within the developing rat central nervous system 26 , our results demonstrate an early (within the first 7 days) and absolute requirement for P 4 during blastulation and neurulation as indicated by the findings that, 1) RU-486 prevents normal cavitation of hESC colonies and columnar neuroectodermal rosette formation, 2) RU-486 prevents nestin expression, 3) P 4 induces nestin expression in hESC, 4) P 4 withdrawal from pre-EBs inhibits neuroectodermal rosette formation, and 5) hCG upregulates StAR processing for cholesterol transport and P 4 synthesis and secretion. Thus, these results suggest that paracrine/juxtacrine signaling of hCG for mobilization of cholesterol for P 4 production by the epiblast/synctiotrophoblast following conception is essential for blastulation and neurulation. Conversely, suppression of P 4 signaling at this time (e.g.
with RU-486) 27 will block these time-sensitive developmental processes. The requirement of P 4 during cavitation processes indicates the structural influence of these molecular pathways on the developing embryo within the first 7 days, but also on the formation of the neural tube at around day 17-19, which will influence future neural connectivity. Thus, there exists a critical molecular signaling link between trophoblastic (and/or maternal) hormone production and early embryonic growth and development. 
